期刊文献+

舒肝解毒汤治疗慢性乙型肝炎的效果分析 被引量:2

Effect of Shugan Jiedu Decoction on Chronic Hepatitis B
下载PDF
导出
摘要 目的探讨舒肝解毒汤治疗慢性乙型肝炎的效果。方法回顾性分析收治的慢性乙型肝炎患者112例临床资料,分为对照组和观察组,各56例,对照组采取常规护肝治疗,观察组采取舒肝解毒汤治疗,对比两组乙肝病毒标记物转阴率和证候积分情况。结果观察组的HBe Ag转阴率(46.43%)高于对照组(23.21%)(P<0.05);观察组证候积分均低于对照组(P<0.05)。结论对慢性乙型肝炎采取舒肝解毒汤治疗效果显著,安全可靠,无明显不良反应及毒副作用。 Objective To explore the effect of Shugan Jiedu Decoction in treating chronic hepatitis B. Methods The clinical data of 112 cases of chronic hepatitis B patients admitted to our hospital were retrospective analyzed, and were divided into the control group and observation group, 56 cases in each group. The control group was given conventional liver treatment, the observation group was given Shugan Jiedu Tang treatment, the negative conversion rate and syndrome integral of HBV markers in the two groups were compared. Results The negative rate of HBeAg in the observation group (46.43%) was higher than that in the control group (23.21%) (P 〈 0.05), and the score of syndrome in the observation group was lower than that in the control group (P 〈 0.05). Conclusion On chronic hepatitis B to take Shugan detoxification soup treatment effect is significant, safe and reliable, no obvious adverse reactions and side effects.
作者 白翎
出处 《中国卫生标准管理》 2017年第18期89-91,共3页 China Health Standard Management
关键词 慢性乙型肝炎 舒肝解毒汤 效果 chronic hepatitis B shugan detoxifcation soup effect
  • 相关文献

参考文献9

二级参考文献93

  • 1潘莉莉,潘荣华.乙肝歧视现象的问题与反思[J].医学与哲学,2005,26(1):77-79. 被引量:12
  • 2张印俊.慢性乙型肝炎的预防与治疗[J].国外医药(抗生素分册),2005,26(5):220-222. 被引量:2
  • 3裴豪,陆忠华,季瑞云,钱金娟,张时良.慢性乙肝患者血清铁蛋白与肝组织病理学的关系[J].临床肝胆病杂志,2006,22(3):182-183. 被引量:13
  • 4尹玉华.慢性乙型肝炎患者的心理健康水平及其与人格和应付方式的相关性[J].中华护理杂志,2006,41(10):947-949. 被引量:35
  • 5Detivaud L,Nemeth E,Boudjema K,et al. Hepcidin levels in humans are correlated with hepatic iron stores,hemoglobin lev- els,and hepatic function. Blood,2005,106:746-748.
  • 6Asare GA,Paterson AC,Kew MC,et al. Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wis- tar rats fed a diet high in iron. Pathology,2006,208:82-90.
  • 7Ozawa E,Abiru S,Nagaoka S,et al. Ferritin/alanine aminotrans- ferase ratio as a possible marker for predicting the prognosis of acute liver. J Gastroenterol Hepatol,2011,26(8):1326-1332.
  • 8Lustbader ED,Hann HW,Blumberg BS. Serum ferritin as a predictor of host response to hepatitis B virus infection. Sci- ence, 1983,220(4595 ):423-425.
  • 9Cujic D,Golubovic S,Bojic-Trbojevic Z,et al. Differential di- agnosis of liver diseases using serum biomarkers. J Buon, 2010,15(1):141-146.
  • 10Woiqd Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection [ R ]. WHO, 2015.

共引文献134

同被引文献85

引证文献2

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部